Osaic Holdings
AVXL icon

Osaic Holdings’s Anavex Life Sciences AVXL Stock Holding History

Osaic Holdings’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.3K Sell
34,466
-4,174
-11% -$12.3K ﹤0.01% 5045
2026
Q1 		$119K Buy
38,640
+6,905
+22% +$29.9K ﹤0.01% 4552
2025
Q4 		$113K Sell
31,735
-10,678
-25% -$65.4K ﹤0.01% 4609
2025
Q3 		$400K Buy
42,413
+4,900
+13% +$49.7K ﹤0.01% 3613
2025
Q2 		$346K Sell
37,513
-4,355
-10% -$37.2K ﹤0.01% 3469
2025
Q1 		$359K Buy
41,868
+10,386
+33% +$98.1K ﹤0.01% 3155
2024
Q4 		$338K Buy
31,482
+22,698
+258% +$175K ﹤0.01% 3144
2024
Q3 		$49.9K Buy
8,784
+6,446
+276% +$37.2K ﹤0.01% 4755
2024
Q2 		$9.87K Sell
2,338
-10,726
-82% -$43.4K ﹤0.01% 5802
2024
Q1 		$66.5K Sell
13,064
-8,456
-39% -$47.6K ﹤0.01% 4529
2023
Q4 		$200K Buy
21,520
+8,591
+66% +$59.1K ﹤0.01% 3926
2023
Q3 		$84.7K Sell
12,929
-213
-2% -$1.7K ﹤0.01% 4626
2023
Q2 		$107K Sell
13,142
-1,652
-11% -$14.2K ﹤0.01% 4383
2023
Q1 		$127K Sell
14,794
-1,844
-11% -$18.4K ﹤0.01% 4243
2022
Q4 		$154K Buy
16,638
+7,065
+74% +$75.5K ﹤0.01% 4084
2022
Q3 		$99K Sell
9,573
-1,813
-16% -$19.1K ﹤0.01% 4385
2022
Q2 		$114K Sell
11,386
-5,645
-33% -$53.5K ﹤0.01% 4308
2022
Q1 		$294K Sell
17,031
-2,056
-11% -$25.3K ﹤0.01% 3700
2021
Q4 		$330K Sell
19,087
-35,609
-65% -$677K ﹤0.01% 3459
2021
Q3 		$981K Buy
54,696
+22,694
+71% +$452K ﹤0.01% 2363
2021
Q2 		$722K Buy
32,002
+21,857
+215% +$324K ﹤0.01% 2637
2021
Q1 		$152K Buy
10,145
+3,758
+59% +$41K ﹤0.01% 3990
2020
Q4 		$35K Sell
6,387
-3,850
-38% -$20.3K ﹤0.01% 4802
2020
Q3 		$46K Sell
10,237
-2,750
-21% -$11.8K ﹤0.01% 4351
2020
Q2 		$64K Sell
12,987
-450
-3% -$1.7K ﹤0.01% 4008
2020
Q1 		$42K Buy
+13,437
New +$46.8K ﹤0.01% 4090

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Osaic Holdings's AVXL Position: Q2 2026 in Review

Osaic Holdings reduced its Anavex Life Sciences (AVXL) stake by 11% in Q2 2026, selling an estimated $12.3K and leaving 34,466 shares worth $89.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5045.

Osaic Holdings first reported a position in AVXL in Q1 2020 and has held it in 26 quarters since. The position peaked at $981K in Q3 2021. 180 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Osaic Holdings held 34,466 shares of Anavex Life Sciences worth $89.3K as of Q2 2026.
  • Osaic Holdings sold 4,174 Anavex Life Sciences shares in Q2 2026, an estimated $12.3K.
  • Anavex Life Sciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5045 holding.
  • Osaic Holdings first reported a position in Anavex Life Sciences in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Anavex Life Sciences position peaked at $981K in Q3 2021.
  • 180 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.